إعلان
إعلان
EBS
Emergent Biosolutions, Inc.
13.94
USDبرعاية
+0.79
+6.01%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
13.91
-0.03
-0.22%
تقارير أرباح EBS
النسبة الإيجابية المفاجئة
EBS تفوق 21 من 40 آخر التقديرات.
53%
التقرير التالي
بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$219.68M
/$0.11
التغير الضمني من Q3 25 (Revenue/ EPS)
-4.94%
/-89.62%
التغير الضمني من Q4 24 (Revenue/ EPS)
+12.83%
/+120.00%
Emergent Biosolutions, Inc. earnings per share and revenue
On ٢٩ أكتوبر ٢٠٢٥, EBS reported earnings of 1.06 USD per share (EPS) for Q3 25, beating the estimate of -0.12 USD, resulting in a 974.59% surprise. Revenue reached 231.10 مليون, compared to an expected 195.94 مليون, with a 17.94% difference. The market reacted with a +36.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of 0.11 USD, with revenue projected to reach 219.68 مليون USD, implying an نقصان of -89.62% EPS, and نقصان of -4.94% in Revenue from the last quarter.
الأسئلة الشائعة
What were Emergent Biosolutions, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Emergent Biosolutions, Inc. reported EPS of $1.06, beating estimates by 974.59%, and revenue of $231.10M, 17.94% above expectations.
How did the market react to Emergent Biosolutions, Inc.'s Q3 2025 earnings?
The stock price moved up 36.6%, changed from $9.40 before the earnings release to $12.84 the day after.
When is Emergent Biosolutions, Inc. expected to report next?
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
What are the forecasts for Emergent Biosolutions, Inc.'s next earnings report?
Based on 4
المحللين, Emergent Biosolutions, Inc. is expected to report EPS of $0.11 and revenue of $219.68M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان